About Dynavax Technologies Corp.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

At the moment the company generates 21M USD in revenues.

On its last earning announcement, the company reported a loss of -2.57$ per share.

The book value per share is 2.10$

Dynavax Technologies Corp. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
21M 3.10% -145M -694.90% -163M -2.57 - - 64M 2.10 -144M -22M -166M